• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home / Exclusive

Govt places orders for 1.45 cr doses of COVID-19 vaccines

Additional order placed on Serum Institute and Bharat Biotech

  • Press Trust of India
  • Last Updated : February 9, 2021, 19:51 IST
  • Follow
Ahmedabad: Policemen pose for a group photograph after being administered with the first dose of Covishield vaccine, during a countrywide inoculation drive against COVID-19
  • Follow

New Delhi: The government has placed orders for one crore additional doses of Covishield from Serum Institute of India and 45 lakh more doses of Covaxin from Bharat Biotech, officials of the two vaccine makers said on Tuesday. India’s COVID-19 vaccination drive was launched by Prime Minister Narendra Modi on January 16. Serum Institute has received another order from the government for 10 million doses of Covishield, a company official said in response to a query. The government had earlier placed a purchase order with Serum Institute of India (SII) for 1.1 crore doses of AstraZeneca-Oxford COVID-19 vaccine, Covishield. When asked, a Bharat Biotech spokesperson said, “The company has received a letter of comfort from the Government of India to supply another 4.5 million (or 45 lakh) doses”. The spokesperson also added that Bharat Biotech will also be exporting its COVID-19 vaccine, Covaxin, to Brazil and the United Arab Emirates. The company is also likely to export the vaccine to the Philippines and other South Asian countries, the spokesperson said. The government had earlier placed an order for 55 lakh doses of Covaxin from Bharat Biotech.

Published: February 9, 2021, 19:51 IST

Download Money9 App for the latest updates on Personal Finance.

  • Covid
  • serum institute
  • vaccine

Related

  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • भारत-रूस समिट में बड़े फैसलों की तैयारी, इकोनॉमिक पार्टनरशिप पर बड़ा फोकस
  • भारत और यूरोपीय संघ के बीच पैसे भेजना होगा आसान,RBI ने शुरू की UPI TIPS; जानें कैसे करेगा काम
  • श्रम संहिता लागू होने से निर्यातकों को मिलेगा प्रोत्साहन: अधिकारी
  • मारुति सुजुकी ने प्रौद्योगिकी स्टार्टअप में करीब आठ प्रतिशत हिस्सेदारी हासिल की
  • टोयोटा ने डैशबोर्ड के हिस्से को बदलने के लिए 11.5 हजार अर्बन क्रूजर हाइडर वापस मंगाईं

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • DGCA प्रमुख ने सुचारू उड़ान संचालन सुनिश्चित करने के लिए पायलटों से मांगा सहयोग
  • रेपो दर में कटौती से घर के लिए कर्ज होगा सस्ता, मांग बढ़ेगी: रियल एस्टेट
  • मीशो के 5,421 करोड़ रुपये के आईपीओ को दूसरे दिन मिला 7.97 गुना अभिदान
  • इंडिगो को अगले साल 10 फरवरी तक उड़ान संचालन पूरी तरह बहाल होने की उम्मीद
  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2025 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close